• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4835849)   Today's Articles (201)
For: Xu S, Luo W, Zhu M, Zhao L, Gao L, Liang H, Zhang Z, Yang F. Human Serum Albumin-Platinum(II) Agent Nanoparticles Inhibit Tumor Growth Through Multimodal Action Against the Tumor Microenvironment. Mol Pharm 2024;21:346-357. [PMID: 38015620 DOI: 10.1021/acs.molpharmaceut.3c00881] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2023]
Number Cited by Other Article(s)
1
Danişman-Kalindemirtaş F, Özerkan D, Kariper İA, Erdemir Cilasun G, Ülküseven B, Erdem-Kuruca S. Albumin-based nanocarriers loaded with novel Zn(II)-thiosemicarbazone compounds chart a new path for precision breast cancer therapy. Anticancer Drugs 2025;36:208-219. [PMID: 39774332 DOI: 10.1097/cad.0000000000001679] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2025]
2
Tokhtueva MD, Melekhin VV, Abramov VM, Ponomarev AI, Prokofyeva AV, Grzhegorzhevskii KV, Paramonova AV, Makeev OG, Eltsov OS. The arylbipyridine platinum (II) complex increases the level of ROS and induces lipid peroxidation in glioblastoma cells. Biometals 2025;38:185-202. [PMID: 39397212 DOI: 10.1007/s10534-024-00646-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2024] [Accepted: 10/01/2024] [Indexed: 10/15/2024]
3
Li W, Li S, Zhu M, Xu G, Man X, Zhang Z, Liang H, Yang F. Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer. J Med Chem 2024;67:17243-17258. [PMID: 39298516 DOI: 10.1021/acs.jmedchem.4c01133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2024]
4
van Niekerk A, Chakraborty S, Bellis C, Chellan P, Prince S, Mapolie SF. Binuclear palladacycles with ionisable and non-ionisable tethers as anticancer agents. J Inorg Biochem 2024;257:112608. [PMID: 38761581 DOI: 10.1016/j.jinorgbio.2024.112608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 04/30/2024] [Accepted: 05/09/2024] [Indexed: 05/20/2024]
5
Zhao J, Wu K, Yang Y, Liu D, Zhang C, Li X. Novel Pt(IV) complexes containing salvigenin ligand reverse cisplatin-induced resistance by inhibiting Rap1b-mediated cancer cell stemness in esophageal squamous cell carcinoma treatments. Bioorg Chem 2024;147:107384. [PMID: 38643568 DOI: 10.1016/j.bioorg.2024.107384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2024] [Revised: 04/09/2024] [Accepted: 04/16/2024] [Indexed: 04/23/2024]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA